Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population
Background: Copy Number variation (CNVs) in genes related to drug absorption, distribution, metabolism and excretion (ADME) are relevant in the interindividual variability of drug response. Studies of the CNVs in ADME genes in Latin America population are lacking. The objective of the study was to i...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2019
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23573
- Acceso en línea:
- https://doi.org/10.1186/s12920-019-0556-x
https://repository.urosario.edu.co/handle/10336/23573
- Palabra clave:
- Genomic DNA
Cytochrome P450
Glutathione transferase
Adult
Allele
Article
Cohort analysis
Colombian
Copy number variation
CYP-450 gene
CYP1A1 gene
CYP1A2 gene
CYP1B1 gene
CYP2A6 gene
CYP2B6 gene
CYP2C19 gene
CYP2C9 gene
CYP2D gene
CYP2E1 gene
CYP3A4 gene
CYP3A5 gene
DNA isolation
Female
Gene
Gene deletion
Gene duplication
Gene frequency
Genetic profile
Genetic variability
Genotype
GST gene
GSTM1 gene
GSTP1 gene
GSTT1 gene
Human
Male
Normal human
Personalized medicine
Pharmacogenetics
Priority journal
South and Central America
Colombia
Genetics
Colombia
Cytochrome P-450 Enzyme System
DNA Copy Number Variations
Gene Frequency
Genotype
Glutathione Transferase
Humans
Pharmacogenetics
Allele frequency
DNA copy number variation
Personalized medicine
DNA
Pharmacogenomics
- Rights
- License
- Abierto (Texto Completo)
Summary: | Background: Copy Number variation (CNVs) in genes related to drug absorption, distribution, metabolism and excretion (ADME) are relevant in the interindividual variability of drug response. Studies of the CNVs in ADME genes in Latin America population are lacking. The objective of the study was to identify the genetic variability of CNVs in CYP-450 and GST genes in a subgroup of individuals of Colombian origin. Methods: Genomic DNA was isolated from 123 healthy individuals from a Colombian population. Multiplex Ligation-Dependent Probe Amplification (MLPA) was performed for the identification of CNVs in 40 genomic regions of 11 CYP-450 and 3 GST genes. The genetic variability, allelic and genotypic frequencies were analyzed. Results: We found that 13 out of 14 genes had CNVs: 5 (35.7%) exhibited deletions and duplications, while 8 (57.1%) presented either deletions or duplications. 33.3% of individuals carried deletions and duplications while 49.6% had a unique type of CNV (deletion or duplication). The allelic frequencies of the CYP and GST genes were 0 to 47.6% (allele null), 0 to 17.5% (duplicated alleles) and 37 to 100% (normal alleles). Conclusions: Our results describe, for the first time, the genomic profile of CNVs in a subgroup of Colombian population in GST and CYP-450 genes. GST genes indicated greater genetic variability than CYP-450 genes. The data obtained contributes to the knowledge of genetic profiles in Latin American subgroups. Although the clinical relevance of CNVs has not been fully established, it is a valuable source of pharmacogenetic variability data with potential involvement in the response to medications. © 2019 The Author(s). |
---|